Bruker Q4 Revenues up 9 Percent; Job Cuts Ahead | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker today said that revenues for its fourth quarter rose 9 percent year over year, and it beat the average analyst estimates on the top and bottom lines.

Despite the strong finish to the year, a company official said on a conference call following the release of the results that restructuring initiatives are expected to result in layoffs this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.